CAR- T and cell genetics therapies are also expensive

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production and also modern technology transactions can provide cellular genetics therapies at an affordable expense to individuals across the world.